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Background: In cartilage tissue regeneration, it is important to develop
biodegradable scaffolds that provide a structural and logistic template for
three-dimensional cultures of chondrocytes. In this study, we evaluated changes in
expression of cartilaginous genes during in vitro chondrogenic differentiation of
WJ-MSCs on PLGA scaffolds.
Methods: The biocompatibility of the PLGA material was investigated using
WJ-MSCs by direct and indirect contact methods according to the ISO 10993–5
standard. PLGA scaffolds were fabricated by the solvent casting/salt-leaching
technique. We analyzed expression of chondrogenic genes of WJ-MSCs after a
21-day culture.
Results: The results showed the biocompatibility of PLGA and confirmed the
usefulness of PLGA as material for fabrication of 3D scaffolds that can be applied
for WJ-MSC culture. The in vitro penetration and colonization of the scaffolds by
WJ-MSCs were assessed by confocal microscopy. The increase in cell number
demonstrated that scaffolds made of PLGA copolymers enabled WJ-MSC
proliferation. The obtained data showed that as a result of chondrogenesis of
WJ-MSCs on the PLGA scaffold the expression of the key markers collagen type II
and aggrecan was increased.
Conclusions: The observed changes in transcriptional activity of cartilaginous genes
suggest that the PLGA scaffolds may be applied for WJ-MSC differentiation. This
primary study suggests that chondrogenic capacity of WJ-MSCs cultured on the
PLGA scaffolds can be useful for cell therapy of cartilage.
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Articular cartilage is a tissue characterized by a limited regeneration capacity. Current
clinical treatment strategies of cartilage defects do not allow for full regeneration of
damaged tissue [1]. Type II collagen is the most abundant collagen in cartilage, while
the most abundant proteoglycan is aggrecan. Type II collagen primarily endows the
cartilage with its tensile strength, whereas aggrecan provides the osmotic resistance for
cartilage to resist compressive loads. Type I and type III collagens are expressed in
fibrocartilage and degenerating cartilage. Moreover, in vitro cultures of chondrocytes
undergo a dedifferentiation process, gradually changing their morphology to a
fibroblast-like shape, and the production of type II collagen is replaced by the production
of type I collagen typical for fibrocartilage, which as biomechanically inferior compared
with physiological hyaline cartilage [2, 3]. It is crucial for cartilage tissue engineering to
develop biodegradable scaffolds that provide a structural and logistic template for three-
dimensional (3D) cultures of chondrocytes [4]. If possible, the scaffold should have di-
rected and controlled degradation, promote cell viability, differentiation, and extracellular
matrix (ECM) production, allow for the diffusion of nutrients and waste products, and
provide mechanical integrity depending on the defect size and location [5]. Aliphatic poly-
esters such as polylactide (PLA), polyglycolide (PGA), poly-ɛ-caprolactone and its copoly-
mers can degrade in contact with living tissue or under the influence of external factors.
Biodegradation occurs as a result of their hydrolysis to lactic acid and glycolic acid [6, 7].
Homopolymers themselves are not optimum materials for forming the 3D scaffolds for
cartilage tissue regeneration. PGA is characterized by very hydrophilic properties,
resulting in rapid degradation. In contrast, the degradation process of PLA is too slow.
Copolymers of PLA and PGA can be easily optimized for mechanical and degradation
properties by optimizing their synthesis conditions and applying appropriate
polymerization initiators [8].
PLGA has proved to be an excellent material for cartilage tissue engineering due to
its biodegradable properties, mechanical strength, and ease of fabrication into a consid-
erably complex formation. Moreover, PLGA is a synthetic material that has excellent
biocompatibility [6, 9, 10].
An important stimulus for the development of research in the field of tissue
engineering is to find sources of stem cells, capable of being differentiated towards a
specific cell type. Mesenchymal stem cells (MSCs) due to their superior proliferative
and differentiation capacities offer an attractive source [9]. While the most thoroughly
characterized populations of MSCs are bone marrow-derived stem cells (BMSCs) or
adipose mesenchymal stem cells (ADSCs), Wharton’s jelly mesenchymal stem cells
(WJ-MSCs) have drawn attention as they can easily be obtained in large quantities and
show characteristics comparable to BMSCs or ADSCs [5, 11]. It has been reported that
WJ-MSCs may in vitro differentiate towards chondrocytes, osteoblasts, cardiac muscle
cells, skeletal muscle cells, adipocytes, β cells in the islets of Langerhans or endothelial
cells [12].
The aim of this study was to evaluate the changes in transcriptional activity of genes
related to hyaline cartilage and fibrocartilage during chondrogenesis of WJ-MSCs on
copolymer poly (L-lactide-co-glycolide) (PLGA) scaffolds for feasibility to recover
cartilage structures in vitro. Chondrocytes were used as a reference material during
analyses of the gene expression pattern of differentiated cells.
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Isolation, culture and phenotype characterization of WJ-MSCs
Isolation of WJ-MSCs was carried out using the explant method [13]. Human umbilical
cord samples (n = 7) were collected following full term deliveries at the Department of
Gynecology and Obstetrics of the Medical University of Silesia, Katowice, Poland
(Central Clinical Hospital in Katowice). The patients were informed and agreed on the
sampling and the purposes, and the Bioethical Committee of the Medical University of
Silesia in Katowice approved the use of the samples for this research. WJ-MSCs were
cultured under standard conditions (humidified atmosphere with 5 % CO2 at 37 °C), in
a growth medium containing α-modified Minimum Essential Medium Eagle with
L-glutamine and sodium bicarbonate (α-MEM; Sigma-Aldrich) supplemented with
20 % fetal bovine serum (FBS; Life Technologies), penicillin (100 U/ml; Sigma
Aldrich), streptomycin (100 μg/ml; Sigma Aldrich) and 1 % Non-Essential Amino
Acid Solution (NEAA; Sigma Aldrich).
Flow cytometry immunophenotypic analysis of WJ-MSCs from the third passage was
performed using a Human MSC Analysis Kit (BD Biosciences) according to the manu-
facturer’s protocol. This kit includes the panel of antibodies for detecting cell surface
markers for the minimal identification of human MSCs, which was proposed by the
International Society for Cellular Therapy. The kit contained an MSC-positive cocktail
of antibodies: fluorescein isothiocyanate (FITC) mouse anti-human CD90, peridinin
chlorophyll protein-cyanine dye (PerCP-Cy5.5) mouse anti-human CD105, allophyco-
cyanin (APC) mouse anti-human CD73 and negative MSC cocktail phycoerythrin (PE)
conjugated antibodies (PE mouse anti-human CD45, PE mouse anti-human CD34, PE
mouse anti-human CD11b, PE mouse anti-human CD19, and PE mouse anti-human
HLA-DR). A BD FACSAria II flow cytometer with FACS Diva Software 6.1.2 was used
in this research. A commercial line of WJ-MSCs (PromoCell) from the third passage
was used for a comparison.Chondrocyte culture
Normal human articular chondrocytes from the hyaline cartilage of the knee were pur-
chased from Lonza. Chondrocytes were cultured in growth medium containing α-MEM
(Sigma-Aldrich), FBS (10 %; Life Technologies), penicillin (100 U/ml; Sigma Aldrich),
streptomycin (100 μg/ml; Sigma Aldrich) and NEAA (1 %; Sigma Aldrich). Chondrocytes
from the third passage were used in these experiments.PLGA biocompatibility
The biocompatibility of PLGA (molar ratio of 85:15) was tested in vitro using WJ-
MSCs (seeding density: 2.5×104 cells/cm2) by direct and indirect contact methods
according to the ISO standard (ISO 10993–5) [14]. PLGA discs of 5 mm diameter were
obtained by molding using methylene chloride and by molding under pressure. The
cytotoxicity assessment of PLGA was performed using ultra-high molecular weight
polyethylene (UHMWPE), which is a nontoxic material, and polyvinyl chloride (PVC)
for a positive control. In the indirect contact test, copolymer and positive/negative
control discs were placed in inserts with a pore diameter of 0.4 μm (SPL Life Sciences).
In direct contact tests, either the PLGA discs, the negative control UHMWPE discs or
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was performed in triplicate.
After cell exposure to the disc the viability of WJ-MSCs was assessed at 72 h and
120 h with In Vitro Toxicology Assay Kit, XTT based (TOX-2; Sigma Aldrich)
according to the manufacturer’s protocol. This test provides a spectrophotometric
method for estimating cell number based on the mitochondrial activity in living cells. A
key component of this test is the sodium salt of XTT (2,3-bis[2-methoxy-4-nitro-5-sul-
fophenyl]-2H-tetrazolium-5-carboxyanilide inner salt), which is reduced by mitochon-
drial dehydrogenases of viable cells. Reduction of the tetrazolium ring of XTT yields an
orange formazan derivative, which is water soluble and is measured spectrophotomet-
rically. An increase or decrease in viable cells relative to control cells results in a
change in the amount of formazan formed, indicating the degree of cytotoxicity caused
by the tested material [15].Fabrication of scaffold
In this study we used scaffolds fabricated from PLGA. A copolymer of poly(L-lactide-
co-glycolide) in a molar ratio of 85:15 was synthesized using zirconium acetylacetonate
– a non-toxic initiator of polymerization. The copolymer was characterized by the
number average molecular weight (Mn) of 50 kDa and the weight average molecular
weight (Mw) of 105 kDa. Scaffolds were fabricated by the solvent casting/salt-leaching
technique as described by Pamuła et al. in the Centre of Polymer and Carbon Materials
(Polish Academy of Sciences) [16]. Microstructure of obtained PLGA scaffolds was
analyzed by a scanning electron microscope (Quanta 250 FEG, FEI Company;
accelerating voltage 5 kV during scanning), a confocal laser scanning microscope
(Olympus FluoView), and an inverted phase contrast microscope (Nikon Eclipse TS100).Invasion of the PLGA scaffolds by WJ-MSCs
WJ-MSCs (seeding density: 5×106 cells per scaffold) were loaded into the pores of
PLGA scaffolds in a growth medium containing α-modified Minimum Essential
Medium Eagle with L-glutamine and sodium bicarbonate (α-MEM; Sigma-Aldrich)
supplemented with 20 % fetal bovine serum (FBS; Life Technologies), penicillin (100 U/ml;
Sigma Aldrich), streptomycin (100 μg/ml; Sigma Aldrich) and 1 % Non-Essential Amino
Acid Solution (NEAA; Sigma Aldrich). To observe the effects of seeding, the cells were
stained with CellLight Tubulin-GFP BacMan 2.0 (Life Technologies) reagent according to
the manufacturer’s protocol. The reagent labels tubulin with green fluorescent protein
(GFP) in live cells. The invasion of the scaffolds by WJ-MSCs was assessed at days 1, 7, and
14 of culture in the growth medium, using a confocal laser scanning microscope (Olympus
FluoView).In vitro chondrogenesis
WJ-MSCs and chondrocytes from the third passage were used for all chondrogenic
experiments. Cells were grown in 2D cell culture dishes in growth medium (seeding
density: 5×103 cells/cm2 for WJ-MSCs and 1×104 cells/cm2 for chondrocytes) and
chondrogenic medium (seeding density: 2.5×104 cells/cm2 for WJ-MSCs and chondro-
cytes). Cells were also grown on 3D PLGA scaffolds in growth medium (seeding
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medium (seeding density: 5×106 cells per scaffold for WJ-MSCs and chondrocytes).
Chondrogenesis was induced by a chondrogenic medium containing: α-MEM (Sigma
Aldrich), dexamethasone (100 nM; Sigma Aldrich), TGF-β3 (10 ng/ml; Gene Way), ITS
+ Premix (1 %; BD Biosciences), ascorbic acid 2-phosphate (50 μg/ml; Sigma Aldrich),
FBS (2 %; Life Technologies), NEAA (1 %; Sigma-Aldrich), penicillin (100 U/ml; Sigma
Aldrich), streptomycin (100 μg/ml; Sigma Aldrich) and sodium pyruvate (1 %; Life
Technologies) [17, 18]. All the cultures were grown for 21 days. Finally, after this time
period total RNA was isolated from all cultures and real-time PCR analysis was per-
formed. The calibrators (controls) used to analyze the relative changes in gene expres-
sion for the 2D environment were WJ-MSCs and chondrocytes respectively, which
were grown in cell culture dishes (2D) in growth medium. For the 3D culture system
the calibrators (controls) used to analyze the relative changes in gene expression were
WJ-MSCs and chondrocytes respectively, which were grown on PLGA scaffolds in
growth medium.RNA isolation and real-time PCR analysis
The total RNA was extracted using the RNeasy Mini Kit (Qiagen), according to the
manufacturer’s protocol. To remove possible contamination of DNA, samples were
treated with DNase I solution. The amount of isolated RNA was checked using the
Quant-IT RiboGreen RNA Reagent Kit (Life Technologies). Fluorometric measurement
results allowed the determination of the starting amount of samples for real-time PCR.
Real-time PCR was performed in one step using the Power SYBR Green RNA-to-Ct
1-Step Kit (Applied Biosystems). This reaction was carried out using primers specific to
a given sequence (Table 1). The expression of the following genes was examined: colla-
gen type I, collagen type II, collagen type III and aggrecan. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as a reference gene. The reaction conditions were
as follows: an initial denaturation (95 °C for 5 min), polymerase activation (95 °C for
10 min) followed by 39 cycles of denaturation (95 °C for 15 s), annealing (60 °C for
30 s), and extension (72 °C for 30 s). To ensure reliability of the results obtained, each
sample was analyzed in triplicate. Quality of the PCR products was checked by melting
curve analysis. To calculate the differences in transcriptional activity of the analyzedTable 1 Sequences of primers used for real-time PCR
Gene Primer sequences Accession no. Amplicon length (bp)
GAPDH 5’ GAAGGTGAAGGTCGGAGTC 3’ NM_002046.3 226
5’ GAAGATGGTGATGGGATTTC 3’
Collagen type I 5’ CCACCAATCACCTGCGTACA 3’ NM_000088 119
5’ CATCGCACAACACCTTGCC 3’
Collagen type II 5’ TGCTGACGCTGCTCGTCGC 3’ NM_001844.4 163
5’ TCGTCGCAGAGGACAGTCCCA 3’
Collagen type III 5’ CAGCAGGGTGCAATCGGCAGT 3’ NM_000090 177
5’ TGGTTGCCCTGGGTGGCCT 3’
Aggrecan 5’ CAAGAGCAGTGCAATCGTTGG 3’ NM_001135.2 127
NM_013227.25’ ACATTCAGCTGCGGTTCCG 3’
Paduszyński et al. Cellular & Molecular Biology Letters  (2016) 21:14 Page 6 of 15genes between treatment and control samples (calibrator), the ΔΔCT method was used.
Determining gene expression profiles and statistical analysis was performed using REST
2009 software (Qiagen).Statistical analysis
The results of the experiment evaluating the biocompatibility of PLGA material were
checked for normality with the Shapiro-Wilk test. The statistical differences between
groups were calculated using one-way analysis of variance (ANOVA). To determine the
homogeneity of variance the Brown-Forsyth test was used. To assess statistically sig-
nificant differences between the means an LSD (least significant difference) test was
performed (StatSoft, Inc. 2011, STATISTICA version 10). Relative gene expression
analyses were performed using the software REST 2009 (Qiagen). Statistical significance
was declared at p < 0.05.Results
WJ-MSC culture and phenotype characterization
The cells that had migrated from the explants were able to adhere and proliferate on
the surface of the polystyrene culture dishes, which is characteristic for MSCs. The
obtained cell lines of WJ-MSCs were able to grow in vitro in culture for a number of
passages. Cells were cultured using the initial density range of 3×103-5×103 cells/cm2.
WJ-MSCs reached confluence in culture vessels after 5–7 days of incubation under
standard conditions.
Immunophenotypic analysis of WJ-MSCs by flow cytometry revealed cells with high
expression of CD73 (91 % of the cells; Fig. 1c), CD105 (91 % of the cells; Fig. 1d) and
CD90 (95.4 % of the cells; Fig. 1e) markers and absent expression of hematopoietic
markers (94.6 % of the cells) such as CD45, CD34, CD11b, CD19 and HLA-DR
(Fig. 1b).PLGA biocompatibility
The results of the direct contact test, after 72 h of WJ-MSCs’ exposure to PLGA discs
obtained by molding using methylene chloride, show a 10 % decrease in viability of
WJ-MSCs compared to the control. A similar effect was observed in cultures with the
PLGA discs obtained by molding under pressure. In the case of the PVC discs (positive
control), an approximately 20 % decrease in cell viability compared with that in the
control was observed. The negative control, where cells were treated with UHMWPE,
was also characterized by a slight reduction (8 %) of viability relative to the control
(Fig. 2a). After 120 h of culture of WJ-MSCs with PLGA discs obtained by molding
using methylene chloride, we observed slight inhibition (11 %) of the metabolic activity
of cells in comparison to control cells. Also WJ-MSCs cultured with PLGA discs
obtained by molding under pressure showed a 13 % decrease of viability in comparison
to control culture. WJ-MSC exposure to PVC discs was characterized by the largest
reduction (21 %) in cell metabolic activity compared to controls. The changes of WJ-
MSCs’ viability in culture with UHMWPE discs were not statistically significant
(Fig. 2a). The obtained results demonstrated that the PLGA copolymer is a highly bio-
compatible material. Inhibition of growth in the experimental groups was not more
Fig. 1 Scattergrams representing the profile of isolated WJ-MSC samples analyzed by flow cytometry
evaluating the cell surface markers. a Dot plot presenting data from forward scatter (FSC) and side scatter
(SSC) detectors and percentage of living cells; b dot plot presenting fluorescence signal from negative
cocktail of PE conjugated antibodies (PE CD45, PE CD34, PE CD11b, PE CD19 and PE HLA-DR) and data from
SSC; c dot plot presenting fluorescence signal from APC-CD73 antibodies and data from SSC; d dot plot
presenting fluorescence signal from PerCP-Cy 5.5-CD105 antibodies and data from SSC; e dot plot presenting
FITC CD90 antibody fluorescence signal and data from SSC; in the plot in panel B the percentage of negative
cells for hematopoietic markers and in the plots in panels C-E the percentage of positive cells for certain
MSC markers are shown
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Fig. 2 Viability of WJ-MSCs evaluated using two methods: a – direct contact, b – indirect contact with PLGA
biomaterial and reference materials after 72 h and 120 h of culture, expressed as a percentage of control
(100 %); mean ± standard deviation; * p < 0.05 (ANOVA with post hoc LSD test), PVC – polyvinyl chloride,
PLGA – poly(L-lactide-co-glycolide); UHMWPE – ultra-high molecular weight polyethylene
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for biocompatible materials in cell cultures in vitro.
To assess the biocompatibility of PLGA in relation to WJ-MSCs the indirect contact
test with inserts (Fig. 2b) was used. After 72 h of WJ-MSCs’ exposure to the PLGA
discs (obtained by molding under pressure and using methylene chloride) determin-
ation of cell proliferation showed no differences compared to the control. The viability
of WJ-MSCs in cultures which were positive or negative controls showed no difference
compared with that in the control. After 120 h of cultivation, the XTT results showed
that the cultures with PLGA discs, produced by using methylene chloride, and by
molding under pressure, were characterized by slight inhibition of proliferation (about
6 % and 9 % respectively) compared to the control. The highest inhibition of metabolic
activity of the cells was observed in the negative control cultures. Viability determin-
ation of WJ-MSCs in cultures with UHMWPE showed no difference compared to the
control culture. The results from indirect contact tests showed biocompatibility of
PLGA in accordance with the guidelines of ISO 10993–5. The obtained results
confirmed the usefulness of PLGA as material for fabrication of 3D scaffolds that
can be applied for WJ-MSC culture. Similar analyses were carried out using chon-
drocytes and fibroblasts, where biocompatibility of PLGA was confirmed (data not
shown).
Characteristics of PLGA scaffolds
The obtained PLGA scaffolds were characterized by the following parameters: density
of polymer (ρp) = 1.0063 g/cm
3, volume of water in pores of the scaffold (Vpores) =
0.24644 cm3, volume of polymer (Vpolymer) = 0.2404 cm
3, porosity of scaffold (P0) =
50.7 %, and absorbency of scaffold (A) = 50.4 %. Analysis of these parameters showed
that the obtained scaffolds made of PLGA were characterized by a porous structure
with adequate stiffness and absorbency. High rigidity of the PLGA scaffolds can provide
adequate mechanical properties and can retain high stability, even during long-term cell
culture. The obtained scaffolds have sufficient porosity, and their pore size provides
high water permeability in in vitro cultures. The analysis of the microstructure of
PLGA scaffolds by scanning electron, confocal laser scanning and inverted phase
contrast microscopy (Fig. 3) showed the pore size in the range of 200–500 μm.
Fig. 3 Microstructure and macrostructure of PLGA scaffolds: a scanning electron micrographs of the cross
section (Quanta 250 FEG; FEI Company), b image from confocal laser scanning microscope (Olympus
FluoView), c morphology of representative PLGA scaffold
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The microscopic analysis of WJ-MSC invasion in 7-day culture showed an increased
number of cells in both upper and bottom surfaces of the scaffold. The depth of inva-
sion of WJ-MSCs was estimated to be 100–120 μm. The largest numbers of cells in the
bottom and upper surfaces of the PLGA scaffolds were observed after 14 days of cul-
ture (Fig. 4). The cells attached to the scaffolds were spindle-shaped. The increase in
cell number demonstrated that scaffolds made of PLGA copolymers enabled WJ-MSCs
proliferation. The highest density of WJ-MSCs occurred in the upper and lower sur-
faces of PLGA scaffolds. The cells also migrated to the middle regions and colonized
the interior pores to a depth of 120 μm.Gene expression
As shown in Fig. 5a, WJ-MSCs cultured in the chondrogenic medium in 2D culture
were characterized by a 1.3-fold increase in the expression of collagen type II when
compared to the 2D culture in growth medium. WJ-MSCs cultured in chondrogenic
medium showed a significant increase in aggrecan expression, approximately 8.53-fold
higher than in 2D culture after 21 days of culture in growth medium. Transcriptional
activity of collagen type I and type III in 2D culture of WJ-MSCs in chondrogenicFig. 4 WJ-MSC invasion of PLGA scaffolds after 14 days of culture in: a – upper and b – bottom surface
(confocal laser scanning microscope Olympus FluoView, magnification 100x)
Fig. 5 Transcriptional activity of collagen type II, aggrecan, collagen type I, and collagen type III genes
expressed as fold change in relation to control (expression = 1) in WJ-MSCs cultured for 21 days on:
a 2D – monolayer, b 3D PLGA scaffold. Control culture was carried out in growth medium in: a 2D –
monolayer, b PLGA scaffold. Growth medium contained inter alia α-MEM medium with 20 % FBS.
Chondrogenic medium contained inter alia differentiation factors such as dexamethasone and TGFβ3, ascorbic
acid 2-phosphate, ITS + Premix, sodium pyruvate and 2 % FBS. * p < 0.05
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to 2D culture in growth medium. In contrast, WJ-MSCs cultured on PLGA scaffold in
chondrogenic medium were characterized by 1.6-fold increased expression of a key
marker of chondrogenesis – collagen type II – compared to PLGA scaffold culture in
growth medium (Fig. 5b). The expression of aggrecan was approximately 1.8-fold
higher in PLGA scaffold culture in chondrogenic medium compared to PLGA scaffold
culture in growth medium. In contrast, the analysis of transcriptional activity of colla-
gen type I and type III in WJ-MSCs cultured on PLGA scaffold in differentiation
medium showed significantly decreased expression of these genes, approximately 4.13-
fold and 13.5-fold respectively compared to WJ-MSC culture on PLGA scaffold in
growth medium.
As shown in Fig. 6a, chondrocytes in 2D culture in chondrogenic medium showed
minor changes in expression of collagen type II in comparison to 2D culture of chon-
drocytes in growth medium. Chondrocytes in 2D culture exhibited 1.6-fold higher ex-
pression of the aggrecan gene than in 2D culture of chondrocytes in growth medium.
Collagen type I in 2D culture of chondrocytes in chondrogenic medium was character-
ized by 2.94-fold decreased expression in comparison to 2D culture of chondrocytes in
growth medium. In contrast, expression of collagen type III in chondrocytes culturedFig. 6 Transcriptional activity of collagen type II, aggrecan, collagen type I, and collagen type III genes
expressed as fold change in relation to control (expression = 1) in chondrocytes cultured for 21 days on:
a 2D – monolayer, b 3D – PLGA scaffold. Control culture was carried out in growth medium in: a 2D –
monolayer, b PLGA scaffold. Growth medium contained inter alia α-MEM medium with 10 % FBS.
Chondrogenic medium contained inter alia differentiation factors such as dexamethasone and TGFβ3,
ascorbic acid 2-phosphate, ITS + Premix, sodium pyruvate and 2 % FBS. * p < 0.05
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medium. When chondrocytes were grown for 21 days on PLGA scaffold in chondro-
genic medium, the transcriptional activity of collagen type II significantly increased,
about 25.7-fold higher than in PLGA scaffold culture of chondrocytes in growth
medium (Fig. 6b). Another marker of chondrogenesis – aggrecan – was also upregu-
lated in culture of chondrocytes on PLGA scaffold in chondrogenic medium. Expres-
sion of this gene was 5.5-fold higher in comparison to culture of chondrocytes on
PLGA scaffold in growth medium. Transcriptional activity of collagen type I and type
III in culture of chondrocytes in PLGA scaffold in chondrogenic medium increased
about 1.9-fold and 3.1-fold respectively in comparison to chondrocytes which were
grown in growth medium on PLGA scaffold.
Discussion
Successful cartilage tissue engineering requires cells capable of undergoing chondro-
genic differentiation upon treatment with appropriate biochemical and physical regula-
tory factors and a 3D scaffold which can provide the cell adhesion, proliferation,
differentiation and cartilage-specific ECM formation. MSCs can be easily obtained and
cultured for multiple passages without losing differentiation potential. Among MSCs,
BMSCs and ADSCs are most often used for cartilage tissue engineering in vitro and
in vivo [11, 19, 20], but their application in humans is still in the early stages. So far
BMSCs and ADSCs have been compared in both pellet cultures and other 3D culture
systems such as scaffolds, and the results indicated lower chondrogenic potential for
the adipose tissue derived MSCs than for bone marrow-derived MSCs [11, 20, 21].
Extra-embryonic tissue-derived MSCs have multipotent characteristics and proliferate
faster than adult MSCs. Moreover, these cells can be isolated and used without ethical
problems, because extra-embryonic tissues are normally discarded after birth [22].
Therefore, in the present study we decided to assess the feasibility of WJ-MSC differen-
tiation towards chondrocytes on PLGA scaffolds.
The possibility of application of WJ-MSCs in the treatment of cartilage defects results
from their relevant biological properties, in particular the capacity to generate fully dif-
ferentiated, specialized cells of the body including the cartilage cells, immune immatur-
ity, acceptable transplantation in partial HLA incompatibility, low probability of
infection transmission and prolonged self-renewal [22, 23]. In the present work, the
WJ-MSCs isolated from umbilical cord were analyzed by flow cytometry to determine
their phenotype. Immunophenotypic analysis of WJ-MSCs revealed MSCs with high
expression of human MSCs markers and absent expression of hematopoietic protein
on the surface. Moreover, the PLGA biomaterial used in the present experiment
showed high biocompatibility and no impact of any residual solvents on the growth of
WJ-MSCs.
The key objective was to evaluate WJ-MSC chondrogenic gene expression in two
different systems: a 3D cell culture system and a 2D culture. Analysis of changes in
expression of genes related to chondrogenesis of WJ-MSCs over a 21-day culture
showed an increase in the transcriptional activity of collagen type II in PLGA 3D scaf-
fold systems and in 2D culture. Another marker of hyaline cartilage, aggrecan, was also
upregulated both in 2D culture and PLGA scaffold in chondrogenic medium. This may
suggest that WJ-MSCs differentiated into cartilage cells. Transcriptional level of
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2D culture. The expression of another marker of fibrocartilage, collagen type III,
decreased significantly in culture on PLGA scaffold, but increased in 2D culture. On
this basis it can be concluded that PLGA scaffolds with relevant differentiating factors
provide conditions for proper WJ-MSC chondrogenesis in vitro. The results of the
experiment on chondrocytes showed high expression of hyaline cartilage markers –
collagen type II and aggrecan – in the scaffold culture. The observed changes in the
level of collagen type II and aggrecan mRNA – markers of hyaline cartilage – suggest
that the PLGA scaffolds consisting of PLA and PGA (85 : 15) may be applied for WJ-
MSC chondrogenic differentiation. Additionally, during the experiments the WJ-MSC
transdifferentiation was checked. Staining with alizarin s (osteogenic transdifferentia-
tion) and oil red (transdifferentiation into adipocytes) gave negative results in every
case. The chondrogenic capacity of WJ-MSCs was also checked by alcian blue staining
or safranin O staining. In this case the results were always positive.
Wang et al. also demonstrated that PGA scaffolds facilitated chondrogenesis of WJ-
MSCs [24]. Chondrogenic differentiation of WJ-MSCs can be enhanced when cultured
on nanofibrous substrates with a sequential two culture medium environment. The
differentiated WJ-MSCs were able to upregulate the production of hyaluronic acid,
glycosaminoglycans (GAGs) and expression of SOX9, COMP, collagen type II, FMOD
genes [25], which is in agreement with some of our observations.
Scaffolds provide the space available for tissue to develop and the physical support
for cell growth. Use of 3D scaffolds to support and maintain contact between cells and
biochemical factors essential for differentiation is one of the main applications of chon-
drogenic differentiation of MSCs. In addition to the size of the pores, the morphology
can significantly influence the performance of an implanted matrix and the rate of
growth of a tissue. Cell morphology together with cell activity, expression of selected
genes and ECM production are closely connected with macro and microstructure of
scaffolds [3, 26, 27]. Pores of the scaffold facilitate invasion of PLGA by WJ-MSCs and
also provide appropriately high stiffness, which additionally enhances chondrogenesis
activated by bioactive factors such as TGFβ3, dexamethasone and ascorbic acid 2-
phosphate [28]. In the case of chondrogenesis of WJ-MSCs on scaffolds stimulated by
chondrogenic factors, a critical step is establishing cell-ECM and cell-cell interactions
during migration, proliferation and differentiation. This is regulated by the connection
of cell adhesion molecules of the surrounding cells, formation of gap junctions and
changes in the cytoskeletal architecture [3, 29]. Structure and chemical composition of
the scaffold, biochemical inducers and cell communication together activate intracellu-
lar signaling pathways which promote differentiation of WJ-MSCs into chondrocytes.
The 3D environment provided by PLGA scaffolds closely cooperates with chondrogenic
bioactive factors to achieve the desired chondrogenic differentiation of WJ-MSCs and
chondrocytes.
The advantage of using WJ-MSCs in chondrogenesis is their better chondrogenic
potential compared to MSCs derived from other sources, because their native environ-
ment is rich in hyaluronic acid, similarly as in cartilage, and like chondrocytes they are
exposed to very low oxygen tension [25, 30, 31]. Chondrocytes in vivo are exposed to a
low oxygen concentration and still maintain the capacity of proliferation and differenti-
ation. Cartilage has no blood supply, deriving nutrients from the surrounding synovial
Paduszyński et al. Cellular & Molecular Biology Letters  (2016) 21:14 Page 13 of 15fluid. MSCs in lower oxygen tension have a better chondrogenic response in cell
aggregate culture, pellet culture and micromass culture, which is reflected in increased
transcriptional activity of genes related to ECM. This may reflect the fact that, in vivo,
articular cartilage, Wharton’s jelly and bone marrow are reported to exist within a
range of 1 % to 7 % oxygen concentration. A group of transcriptional factors called
hypoxia inducible factors regulates the cellular response to changing oxygen tension.
The downstream targets involve several hydroxylases which are critical in formation of
collagen fibers. However, lower oxygen tension is not the only factor that can in-
fluence chondrogenesis [32–34]. In our experiments with PLGA scaffolds where
cells aggregate or in 2D cell cultures with high cell density, spaces of lower oxygen
tension may occur, and this is probably an additional factor stimulating chondro-
genesis of WJ-MSCs.
A variety of biopolymers can be used as scaffolds for cartilage tissue engineering,
including poly(L-lactide)/poly(ε-caprolactone) [35], poly(ε-caprolactone) [36], and
poly(lactide-coglycolide) [37]. However, these materials may be problematic because
they can induce inflammation due to elevated acidity during polymer degradation [38].
Conclusions
Analysis of the changes in gene expression of cartilaginous extracellular matrix
components of WJ-MSCs cultured on PLGA scaffolds suggests that their chondrogenic
capacity could be useful for cell therapy in cartilage diseases.
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